Brvar Miran, Finderle Zarko, Suput Dusan, Bunc Matjaz
Poison Control Centre, Ljubljana Medical Centre, Ljubljana, Slovenia.
Crit Care Med. 2006 Aug;34(8):2228-30. doi: 10.1097/01.CCM.0000228913.61710.9D.
To evaluate S100B, an astroglial structural protein, during normobaric and hyperbaric oxygen therapy of conscious carbon monoxide (CO)-poisoned rats. So far, the usefulness of hyperbaric oxygen therapy in conscious CO-poisoned patients has been shown with neuropsychological testing. The S100B protein has been demonstrated as a possible biochemical marker and prognostic parameter in CO-poisoned rats.
Randomized, controlled interventional trial.
University laboratory.
: Male Wistar rats weighing 254 +/- 14 g.
The rats were exposed to a mixture of 3,000 ppm CO in air for 60 mins. After CO exposure, the first group of eight conscious rats was exposed to ambient air for 30 mins, the second group of six conscious rats was exposed to 100% normobaric oxygen for 30 mins, and the third group of six conscious rats was exposed to 100% hyperbaric oxygen at 3 bars for 30 mins. Blood samples were taken from the jugular vein just before CO exposure and immediately after oxygen therapy. The level of consciousness was evaluated at the end of exposure, and the survival rate was monitored for 14 days. The S100B concentrations were measured with a commercial immunoluminometric assay.
Analyses of differences in S100B levels between different kinds of therapy before and after treatment showed a global significant difference (p = .002). The post hoc test results showed that S100B levels after therapy of the first group treated with ambient air (0.16 +/- 0.07 microg/L) and the second group treated with normobaric oxygen (0.19 +/- 0.05 microg/L) were similar (p = .741), and both of them were significantly different, with much higher values of S100B levels after therapy, from the third group treated with hyperbaric oxygen (0.06 +/- 0.03 microg/L; p = .018 and p = .002, respectively). All the rats survived.
S100B is elevated in conscious CO-poisoned rats left on ambient air or treated with normobaric oxygen, but not in conscious CO-poisoned rats treated with hyperbaric oxygen.
评估在常压和高压氧治疗清醒一氧化碳(CO)中毒大鼠过程中,星形胶质细胞结构蛋白S100B的变化情况。到目前为止,通过神经心理学测试已证实高压氧疗法对清醒CO中毒患者有效。S100B蛋白已被证明可能是CO中毒大鼠的生化标志物和预后参数。
随机对照干预试验。
大学实验室。
体重254±14 g的雄性Wistar大鼠。
将大鼠暴露于含3000 ppm CO的空气混合物中60分钟。CO暴露后,第一组8只清醒大鼠暴露于环境空气中30分钟,第二组6只清醒大鼠暴露于100%常压氧中30分钟,第三组6只清醒大鼠暴露于3巴的100%高压氧中30分钟。在CO暴露前和氧疗后立即从颈静脉采集血样。在暴露结束时评估意识水平,并监测14天的生存率。用商业免疫发光测定法测量S100B浓度。
对不同治疗方法治疗前后S100B水平差异的分析显示总体差异有统计学意义(p = 0.002)。事后检验结果显示,用环境空气治疗的第一组(0.16±0.07μg/L)和用常压氧治疗的第二组(0.19±0.05μg/L)治疗后的S100B水平相似(p = 0.741),且二者与用高压氧治疗的第三组(0.06±0.03μg/L)治疗后的S100B水平均有显著差异,第三组治疗后的S100B水平值更高(分别为p = 0.018和p = 0.002)。所有大鼠均存活。
暴露于环境空气或接受常压氧治疗的清醒CO中毒大鼠中S100B升高,但接受高压氧治疗的清醒CO中毒大鼠中S100B未升高。